Guardant Health

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$301,665
$281,266
$265,196
$232,088
Gross Profit
196,746
181,774
171,609
150,883
EBITDA
-121,350
-118,991
-82,238
-88,836
EBIT
-129,041
-91,646
-98,878
Net Income
-112,075
-128,494
-92,725
-99,899
Net Change In Cash
301,665
281,266
265,196
232,088
Free Cash Flow
-71,203
-41,932
-45,763
-65,934
Cash
989,291
378,203
580,013
629,143
Basic Shares
131,273
128,657
125,304
124,114

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$982,021
$739,016
$563,948
$449,538
Gross Profit
633,014
449,217
336,896
293,213
EBITDA
-373,907
-390,121
-433,305
-614,910
EBIT
-413,643
-432,508
-476,186
-650,872
Net Income
-416,277
-436,373
-479,449
-654,588
Net Change In Cash
982,021
739,016
563,948
449,538
Cost of Revenue
-348,740
Free Cash Flow
-233,066
-274,943
-345,461
-386,924
Cash
378,203
525,540
1,133,537
141,647
Basic Shares
125,374
122,745
111,988
102,178

Earnings Calls

QuarterEPS
2026-03-31
-$0.45
2025-12-31
-$0.50
2025-09-30
-$0.39
2025-06-30
-$0.44